Analyst consensus rating
SELLAS Life Sciences Group Analyst Rating: none
Direct answer
SELLAS Life Sciences Group's consensus rating is none.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $32.50.
Forecast evidence checked October 15, 2026.
Get free SELLAS Life Sciences Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $11.88
- Average price target
- $32.50
- High price target
- $35.00
- Low price target
- $30.00
- Low target gap
- +152.5%
- Target upside
- +173.6%
- High target gap
- +194.6%
- Target range width
- 42.1%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- October 15, 2026
- Valid through
- October 22, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for SELLAS Life Sciences Group?
SELLAS Life Sciences Group has a verified none consensus. The same dataset has an average price target of $32.50.
How far are SELLAS Life Sciences Group's low and high targets from the recorded price?
The low target implies +152.5%, while the high target implies +194.6%.
How many analysts are included in SELLAS Life Sciences Group's consensus?
The verified consensus includes 2 analysts.
How is SELLAS Life Sciences Group's target upside or downside calculated?
The average target of $32.50 is divided by the recorded price of $11.88, then one is subtracted to produce +173.6%. This does not guarantee a future return.
When was SELLAS Life Sciences Group's analyst forecast verified?
The data was verified on 2026-10-15. The dataset is valid through 2026-10-22.